Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
topic_facet:"62340-29-8"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%2262340-29-8%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%2262340-29-8%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%2262340-29-8%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (27)
1
Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes : A subgroup analysis of the SURPASS J-mono study
enthalten in:
Diabetes, obesity & metabolism
| 2024
von
Osonoi, T.
|
Oura, T.
|
Hirase, T.
Wird geladen...
2
Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3) : A randomized, double-blind, placebo-controlled, phase III trial
enthalten in:
Diabetes, obesity & metabolism
| 2023
von
Wang, W.
|
Yan, X.
|
Cheng, Z.
| +5
Wird geladen...
3
Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy)
enthalten in:
Diabetes, obesity & metabolism
| 2023
von
Yabe, D.
|
Kawamori, D.
|
Seino, Y.
| +2
Wird geladen...
4
Ease-of-use and acceptability of the novel semaglutide 2.4 mg single-dose pen-injector in people with overweight or obesity in the STEP 8 phase III trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Snitker, S.
|
Egebjerg, C.
|
Frederiksen, M.
| +1
Wird geladen...
5
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11) : A randomized, open-label, multinational, phase 3b trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Kellerer, M.
|
Kaltoft, M.
|
Lawson, J.
| +4
Wird geladen...
6
A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Roth, C.
|
Perez, F.
|
Whitlock, K.
| +4
Wird geladen...
7
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China : A 30-week, double-blind, phase 3a, randomized trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Ji, L.
|
Dong, X.
|
Li, Y.
| +8
Wird geladen...
8
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea : A 52-week open-label, randomized phase III trial
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Wang, W.
|
Nevárez, L.
|
Filippova, E.
| +6
Wird geladen...
9
Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide : A model-based approach
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Overgaard, R.
|
Lindberg, S.
|
Thielke, D.
Wird geladen...
10
Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Chen, Y.
|
Huang, C.
|
Cho, Y.
| +5
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Filter aufheben
Thema: 62340-29-8
Medienart
27
Aufsätze
27
E-Artikel
27
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
62340-29-8
27
Clinical Trial, Phase III
27
Glucagon-Like Peptides
27
Journal Article
25
Randomized Controlled Trial
25
Research Support, Non-U.S. Gov't
24
Hypoglycemic Agents
22
type 2 diabetes
19
Glycated Hemoglobin A
19
Immunoglobulin Fc Fragments
19
Recombinant Fusion Proteins
19
WTT295HSY5
19
dulaglutide
16
Multicenter Study
13
Blood Glucose
11
Glucagon-Like Peptide-1 Receptor
11
hemoglobin A1c protein, human
8
Comparative Study
8
GLP-1 analogue
7
2ZM8CX04RZ
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2020-
20
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
27
Englisch
Haven't found what you're looking for?
Wird geladen...